NEWS FROM USA
505(b)2 APPROVAL
|
Approval Date |
Product Name |
NDA Sponsor |
Brand Name |
Prescribing information |
|
13 June 2019 |
Budesonide ER capsules (6 mg and 9 mg) |
Sun Pharma |
Ortikos |
NEW EXCLUSIVITY LISTINGS IN THE ORANGE BOOK
New PC (Patent Challenge) exclusivity listing in the orange book
|
Drug |
Applicant |
Corresponding RLD |
PC exclusivity expiration date |
Other TA holders |
|
Erlotinib hydrochloride tablets |
Mylan |
Tarceva (OSI) |
Natco |
New CGT (competitive generic therapy) exclusivity listing in the orange book
|
Drug |
Applicant |
Corresponding RLD |
CGT exclusivity expiration date |
|
Sildenafil powder for oral suspension |
Novitium |
Revatio (Pfizer) |
NEW PARAGRAPH IV FILING
|
DRUG |
Dosage form |
Corresponding RLD |
Date of Submission |
Type of Submission (Based on Date) |
|
Halobetasol Propionate |
Lotion 0.01% |
Bryhali (Bausch) |
20 Mar. 2019 |
Open First to File# |
|
Gabapentin Enacarbil |
Extended-release Tablets |
Horizant |
29 April 2019 |
Open First to File |
#NDA of Bryhali was approved by USFDA on 6 Nov. 2018. First Para IV filing was done within 4 and half months of FDA approval.
Full list of Paragraph IV Patent certifications: Link
505(b)2 IN PIPELINE
Lamotrigine oral liquid (Eton/Aucta pharma): Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application.
- Eton Pharmaceuticals, Inc has entered into an agreement with Aucta Pharmaceuticals, Inc to acquire U.S. marketing rights for ET-105.
- Aucta pharma submitted the product’s New Drug Application (NDA) to the FDA in May 2019.
- Lamotrigine is currently only approved in tablet formulations, and Eton believes ET-105 will fulfill a significant unmet need for pediatric patients requiring precision dosing.
- Full Press Release: Link
ANDA APPROVALS
|
Approval Date |
Drug Product |
ANDA Sponsor |
Corresponding RLD |
Number Of Other Approved Generics |
|
12 June 2019 |
Inventia |
Invega (Janssen) |
Three |
|
|
12 June 2019 |
Perrigo |
Children’s Claritin (Bayer) |
One (Sun) |
|
|
12 June 2019 |
Hainan polypharma |
Vancocin (Baxter) |
Ten |
|
|
13 June 2019 |
FDC |
Cosopt (Oak pharma) |
Seven |
|
|
14 June 2019 |
Novast |
Cardizem CD (Bausch) |
Seven |
|
|
14 June 2019 |
Zydus |
Lovaza (Smithkline Beecham) |
Six |
|
|
17 June 2019 |
PII |
K-tab (Abbvie) |
One (Virtuvias) |
|
|
18 June 2019 |
Mylan |
Dyloject (javelin) |
None |
If you have any query/suggestion then please write us at pharmacaption@gmail.com

No comments:
Post a Comment